Guangdong Zhongsheng Pharmaceutical Co Ltd Financial Flexibility Index
Guangdong Zhongsheng Pharmaceutical Co Ltd financial flexibility index. Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Financial Flexibility Index of 0.16x as of September 2025. Free cash flow of CN¥170.19 Million (operating CF CN¥88.00 Million minus capex CN¥82.19 Million) represents 0% of total liabilities (CN¥1.04 Billion). See how much free cash does Guangdong Zhongsheng Pharmaceutical Co L generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Financial flexibility index of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. Historical Financial Flexibility Index trend for Guangdong Zhongsheng Pharmaceutical Co Ltd across 19 annual periods. Check Guangdong Zhongsheng Pharmaceutical Co L cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Guangdong Zhongsheng Pharmaceutical Co Ltd Financial Flexibility Index by Year (2006–2024)
Guangdong Zhongsheng Pharmaceutical Co Ltd financial flexibility index by year from 2006 to 2024. Year-by-year free cash flow to debt coverage for Guangdong Zhongsheng Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002317 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.37x | CN¥566.10 Million | CN¥337.84 Million | CN¥1.54 Billion | ▲ +28.0% |
| 2023 | 0.29x | CN¥553.67 Million | CN¥190.61 Million | CN¥1.93 Billion | ▲ +69.5% |
| 2022 | 0.17x | CN¥331.03 Million | CN¥63.07 Million | CN¥1.96 Billion | ▼ -72.4% |
| 2021 | 0.61x | CN¥836.53 Million | CN¥622.77 Million | CN¥1.36 Billion | ▲ +140.4% |
| 2020 | 0.26x | CN¥293.37 Million | CN¥138.93 Million | CN¥1.15 Billion | ▼ -7.7% |
| 2019 | 0.28x | CN¥379.49 Million | CN¥251.16 Million | CN¥1.37 Billion | ▼ -23.9% |
| 2018 | 0.36x | CN¥470.26 Million | CN¥326.78 Million | CN¥1.29 Billion | ▼ -17.2% |
| 2017 | 0.44x | CN¥494.19 Million | CN¥369.91 Million | CN¥1.13 Billion | ▼ -26.6% |
| 2016 | 0.60x | CN¥479.47 Million | CN¥338.28 Million | CN¥801.23 Million | ▲ +172.6% |
| 2015 | 0.22x | CN¥268.82 Million | CN¥192.25 Million | CN¥1.22 Billion | ▼ -70.2% |
| 2014 | 0.74x | CN¥300.14 Million | CN¥100.60 Million | CN¥407.63 Million | ▼ -21.4% |
| 2013 | 0.94x | CN¥222.85 Million | CN¥110.95 Million | CN¥238.04 Million | ▼ -35.9% |
| 2012 | 1.46x | CN¥219.80 Million | CN¥142.38 Million | CN¥150.41 Million | ▼ -47.2% |
| 2011 | 2.77x | CN¥255.96 Million | CN¥70.56 Million | CN¥92.54 Million | ▲ +66.5% |
| 2010 | 1.66x | CN¥158.74 Million | CN¥91.72 Million | CN¥95.53 Million | ▲ +45.7% |
| 2009 | 1.14x | CN¥123.73 Million | CN¥100.89 Million | CN¥108.46 Million | ▲ +76.1% |
| 2008 | 0.65x | CN¥92.35 Million | CN¥72.86 Million | CN¥142.53 Million | ▲ +44.4% |
| 2007 | 0.45x | CN¥75.02 Million | CN¥49.35 Million | CN¥167.17 Million | ▲ +147.3% |
| 2006 | 0.18x | CN¥27.75 Million | CN¥17.91 Million | CN¥152.93 Million | — |